Paul Henneman is the Founder, Chief Executive Officer and President of ValuEngine and ValuEngine Capital Management and Founder/Principal of ValuEngine Capital Management, LLC.  Both are headquartered in Melbourne, Florida.

ValuEngine.com (VE) is a stock valuation and forecasting service founded by Ivy League finance academics. The website Rating and Forecast reports on over 4,200 US stocks, 600 ETFs, 16 Economic Sectors, and over 250 Industry Groups.   The stock reports are 11 pages in length and powered by our quantitative models that evaluate all data fields daily.  ValuEngine provides Rating and Forecast reports on over 4,200 US stocks, 600 ETFs, 16 Economic Sectors, and over 250 Industry Groups.   ValuEngine reports provide access to a huge array of quantitative metrics essential to stock evaluation and decision making.  The three most important proprietary indicators include Ratings (from 1=Strong Sell through 5=Strong Buy); Forecast Price Returns; and Valuations.  The sister company ValuEngine Capital Management offers financial advisory services for individual investors, to auto trade their accounts using ValuEngine research.  Prior to launching ValuEngine, Paul was Director of Operations for DataMax.

Paul has established ValuEngine in the financial sector as a leading quantitative analysis firm with a variety of worldwide partnerships and clients that include such impressive companies as:

• LSEG
• Wells Fargo Advisors
• Scotiabank
• Bloomberg
• Factset
• Markit
• Interactive Brokers
• Fidelity Brokerage Services
• Standard and Poors
• The Globe and Mail

Additional clients include major international hedge funds and money managers. Under his leadership, coverage has steadily expanded to over 5,000 US and Canadian equities with all research updated every day, as well as the addition of ETF research. ValuEngine is now recognized as a leader in independent quantitative research and distributes many thousands of research reports through dozens of distribution channels each month, in addition to online subscriptions and highly customized data feed products.